Sertraline Tablets recall: CGMP Deviations
Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54
Why was Sertraline Tablets recalled?
CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 222033, exp. date 08/31/2024
- Product
- Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54
- Recalling firm
- Legacy Pharmaceutical Packaging LLC
- Quantity
- 161,664 bottles
- Distribution
- CA and AR
- Recall date
- January 3, 2024
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)